A new nanotherapeutic vaccine delivery system developed by researchers at MIT could revolutionize the way we administer vaccines. The researchers have developed a nanotherapeutic platform that uses an engineered nanoparticle to deliver not only the vaccine, but also a second molecule to boost its efficacy. This second molecule, known as an adjuvant, helps stimulate an immune response, making the vaccine more effective. The platform is designed to be highly versatile, and could potentially be used to deliver a wide range of therapeutic molecules. The researchers hope that this technology could make it easier to deliver vaccines in areas where access to medical care is limited.

Read Full Article Here

source: Phys.org